<?xml version="1.0" encoding="UTF-8"?>
<ref id="B36-vaccines-08-00142">
 <label>36.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Lehnardt</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Massillon</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Follett</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Jensen</surname>
    <given-names>F.E.</given-names>
   </name>
   <name>
    <surname>Ratan</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Rosenberg</surname>
    <given-names>P.A.</given-names>
   </name>
   <name>
    <surname>Volpe</surname>
    <given-names>J.J.</given-names>
   </name>
   <name>
    <surname>Vartanian</surname>
    <given-names>T.</given-names>
   </name>
  </person-group>
  <article-title>Activation of innate immunity in the CNS triggers neurodegeneration through a Toll-like receptor 4-dependent pathway</article-title>
  <source>Proc. Natl. Acad. Sci. USA</source>
  <year>2003</year>
  <volume>100</volume>
  <fpage>8514</fpage>
  <lpage>8519</lpage>
  <pub-id pub-id-type="doi">10.1073/pnas.1432609100</pub-id>
  <pub-id pub-id-type="pmid">12824464</pub-id>
 </element-citation>
</ref>
